Delivery Order SPE2DB24D1021-SPE2DB25FEXMM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,898.32 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $12,314.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21 count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $47,164.04 and a completion date of September 8, 2025. The award was made through open competition with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, which serves as...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXMMDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,999.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Loestrin 21 1-20 tablets (21-count units). The contract, which was not set aside and competitively awarded, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through its comprehensive IDC vehicle, which enables the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX contract functions as a flexible global pharmaceutical support vehicle supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for oral contraceptive medication reflects the company's role in supplying routine pharmaceutical products to support federal medical supply chains. The DLA Troop Support is planning to expand pharmaceutical procurement through its Pharmaceutical Prime Vendor Global Program Generation V initiative, which will establish multiple regional contracts with separate contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 6/6/25 |